logo enJosep Carreras Leukaemia Research Institute

  • CatalàCA
  • EspañolES
  • EnglishEN

Main navigation

  • About Us
    • Who we are
      • Welcome
      • Scientific Founding Members
      • Director
      • Mission, Vision and Values
      • Governing bodies
        • Organizational chart
        • Board of Trustees
        • Management commission
        • Internal Scientific Committee
        • Scientific Advisory Board (SAB)
        • Coordinators of the 3 Campuses
        • Research Directors on the Campuses
      • Why a Research Institute focusing on Leukaemia & other malignant blood diseases?
    • Directory
    • Research publications
    • How to find us
      • IJC Campus Clinic-UB
      • Campus ICO-Germans Trias i Pujol
      • Campus Sant Pau
    • Events Calendar
    • Contractors
    • Josep Carreras International Leukaemia Foundation
    • News & Press
      • News
      • Press clippings
    • Administrative Transparency IJC page
    • HR Excellence
  • Research Groups
    • Cancer and Leukemia Epigenetics and Biology Program PEBCL
      • Cancer epigenetics
      • Cancer genetics
      • Chromatin biology laboratory
      • Chromatin, metabolism and cell fate
      • 3D chromatin organization
      • Epigenetics and immune disease
      • Lymphocyte development and disease
      • Regulatory genomics
      • Regulatory RNA and chromatin
      • Epigenetic control of haematopoiesis
      • Transcriptional dynamics in leukemia
      • Cancer Immunogenomics
    • Experimental and Clinical Hematology Program PHEC
      • Acute lymphoblastic leukemia (ALL)
      • Barcelona Endothelium Team (BET)
      • Functional cytomics
      • Myeloid neoplasms
      • Immunohematology and glycobiology
      • Leukemia stem cell group
      • Lymphoid neoplasms
      • Multiple myeloma
      • Myelodysplastic syndromes
      • Stem cell biology, developmental leukemia and immunotherapy
      • Stem cell transplantation and cellular Immunotherapy
      • Epigenetic Therapies
      • Lymphoma Translational Group
      • Oncogenesis and Antitumor Drugs
  • Resources and Services
    • Affymetrix Microarrays Platform (PAM)
    • Cytogenetics Platform
    • IJC Sample Collection for Leukemia and other Hematological Diseases
    • Proteomics Unit
    • Genomics Unit
    • Bioinformatics Unit
  • Training and Education
    • Work with us
  • Our Supporters
    • Stakeholders
    • Companies
    • Alliances
    • Friends
  • CatalàCA
  • EspañolES
  • EnglishEN
  • About Us
    • Who we are
      • Welcome
      • Scientific Founding Members
      • Director
      • Mission, Vision and Values
      • Governing bodies
        • Organizational chart
        • Board of Trustees
        • Management commission
        • Internal Scientific Committee
        • Scientific Advisory Board (SAB)
        • Coordinators of the 3 Campuses
        • Research Directors on the Campuses
      • Why a Research Institute focusing on Leukaemia & other malignant blood diseases?
    • Directory
    • Research publications
    • How to find us
      • IJC Campus Clinic-UB
      • Campus ICO-Germans Trias i Pujol
      • Campus Sant Pau
    • Events Calendar
    • Contractors
    • Josep Carreras International Leukaemia Foundation
    • News & Press
      • News
      • Press clippings
    • Administrative Transparency IJC page
    • HR Excellence
  • Research Groups
    • Cancer and Leukemia Epigenetics and Biology Program PEBCL
      • Cancer epigenetics
      • Cancer genetics
      • Chromatin biology laboratory
      • Chromatin, metabolism and cell fate
      • 3D chromatin organization
      • Epigenetics and immune disease
      • Lymphocyte development and disease
      • Regulatory genomics
      • Regulatory RNA and chromatin
      • Epigenetic control of haematopoiesis
      • Transcriptional dynamics in leukemia
      • Cancer Immunogenomics
    • Experimental and Clinical Hematology Program PHEC
      • Acute lymphoblastic leukemia (ALL)
      • Barcelona Endothelium Team (BET)
      • Functional cytomics
      • Myeloid neoplasms
      • Immunohematology and glycobiology
      • Leukemia stem cell group
      • Lymphoid neoplasms
      • Multiple myeloma
      • Myelodysplastic syndromes
      • Stem cell biology, developmental leukemia and immunotherapy
      • Stem cell transplantation and cellular Immunotherapy
      • Epigenetic Therapies
      • Lymphoma Translational Group
      • Oncogenesis and Antitumor Drugs
  • Resources and Services
    • Affymetrix Microarrays Platform (PAM)
    • Cytogenetics Platform
    • IJC Sample Collection for Leukemia and other Hematological Diseases
    • Proteomics Unit
    • Genomics Unit
    • Bioinformatics Unit
  • Training and Education
    • Work with us
  • Our Supporters
    • Stakeholders
    • Companies
    • Alliances
    • Friends
  • Who we are
  • Directory
  • Research publications
  • How to find us
  • Events Calendar
  • Contractors
  • Josep Carreras International Leukaemia Foundation
  • News & Press
  • Administrative Transparency IJC page
  • HR Excellence
N_Deharo_

Nuri De Haro

Groups:

  • Myelodysplastic syndromes

Position at Josep Carreras Institute:

Technician

Contact:

+34 935 572 808ndeharo@carrerasresearch.orgIMPPC Building ICO-GTiP Campus
Ctra. de Can Ruti, Camí de les Escoles s/n
08916 Badalona, Barcelona, Spain

Campus ICO-Germans Trias i Pujol

Germans Trias i Pujol logo

Josep Carreras Leukaemia Research Institute (IJC)
Ctra de Can Ruti, Camí de les Escoles, s/n
08916 Badalona
Spain
Tel: (+34) 93 557 2800
Fax: (+34) 93 465 1472

  • Twitter Logo
  • Linkedin logo
  • CERCA logo

The IJC is a CERCA center.

  • English FIJC logo

Contact

  • Contact list icon

    List of Contacts

  • How to reach us icon

    How to reach us

  • Webmail
  • Site map
  • Legal notice
  • Accessibility

Sponsors

Generalitat de Catalunya logo
Universitat Autònoma de Barcelona logo
Universitat de Barcelona logo
Ajuntament de Badalona logo